Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Schnabel

Showing results (251-260 of 346) with videos related to

Pageof 35
Sort By:
JAMA Cardiology|July 21, 2016
Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour AlgorithmJohannes Tobias Neumann, Nils Arne Sörensen, Tjark Schwemer, et al.
European Heart Journal|August 27, 2021
Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trialStephan Willems, Katrin Borof, Axel Brandes, et al.
Clinical Chemistry|December 2, 2016
Immediate Rule-Out of Acute Myocardial Infarction Using Electrocardiogram and Baseline High-Sensitivity Troponin IJohannes Tobias Neumann, Nils Arne Sörensen, Francisco Ojeda, et al.
The New England Journal of Medicine|August 28, 2009
Sensitive troponin I assay in early diagnosis of acute myocardial infarctionTill Keller, Tanja Zeller, Dirk Peetz, et al.
Internal and Emergency Medicine|September 21, 2020
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation RegistryGiulia Renda, Ladislav Pecen, Giuseppe Patti, et al.
Cardiovascular Diabetology|November 16, 2021
Association of glycated hemoglobin A<sub>1c</sub> levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortiumChristoph Sinning, Nataliya Makarova, Henry Völzke, et al.
Eclinicalmedicine|November 3, 2025
Estimated atrial fibrillation burden on early rhythm-control and cardiovascular events in the EAST-AFNET 4 trialStef Zeemering, Katrin Borof, Ulrich Schotten, et al.
European Heart Journal|July 19, 2024
Genetic testing in early-onset atrial fibrillationShinwan Kany, Sean J Jurgens, Joel T Rämö, et al.
Cardiovascular Research|April 13, 2024
Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule studyLarissa Fabritz, Winnie Chua, Victor R Cardoso, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 20, 2014
Development of a risk score for outcome after transcatheter aortic valve implantationMoritz Seiffert, Jan-Malte Sinning, Alexander Meyer, et al.
Pageof 35

Showing results (251-260 of 346) with videos related to

Sort By:
Pageof 35
JAMA Cardiology|July 21, 2016
Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour AlgorithmJohannes Tobias Neumann, Nils Arne Sörensen, Tjark Schwemer, et al.
European Heart Journal|August 27, 2021
Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trialStephan Willems, Katrin Borof, Axel Brandes, et al.
Clinical Chemistry|December 2, 2016
Immediate Rule-Out of Acute Myocardial Infarction Using Electrocardiogram and Baseline High-Sensitivity Troponin IJohannes Tobias Neumann, Nils Arne Sörensen, Francisco Ojeda, et al.
The New England Journal of Medicine|August 28, 2009
Sensitive troponin I assay in early diagnosis of acute myocardial infarctionTill Keller, Tanja Zeller, Dirk Peetz, et al.
Internal and Emergency Medicine|September 21, 2020
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation RegistryGiulia Renda, Ladislav Pecen, Giuseppe Patti, et al.
Cardiovascular Diabetology|November 16, 2021
Association of glycated hemoglobin A<sub>1c</sub> levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortiumChristoph Sinning, Nataliya Makarova, Henry Völzke, et al.
Eclinicalmedicine|November 3, 2025
Estimated atrial fibrillation burden on early rhythm-control and cardiovascular events in the EAST-AFNET 4 trialStef Zeemering, Katrin Borof, Ulrich Schotten, et al.
European Heart Journal|July 19, 2024
Genetic testing in early-onset atrial fibrillationShinwan Kany, Sean J Jurgens, Joel T Rämö, et al.
Cardiovascular Research|April 13, 2024
Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule studyLarissa Fabritz, Winnie Chua, Victor R Cardoso, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 20, 2014
Development of a risk score for outcome after transcatheter aortic valve implantationMoritz Seiffert, Jan-Malte Sinning, Alexander Meyer, et al.
Pageof 35